Enhanced Tumor Localization of Monoclonal Antibody by Treatment with Kininase II Inhibitor and Angiotensin II

Japanese Journal of Cancer Research

Volumn 83, Issue 3, 1992, Pages 240-243

  Noguchi, Akinori ^a   Takahashi, Toshio ^a   Yamaguchi, Toshiharu ^a   Kitamura, Kazuya ^a   Noguchi, Akira ^a   Tsurumi, Hiroshi ^a   Takashina, Ken‐ichiroh ^a   Maeda, Hiroshi ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Key words; Kinin generating cascade; Kininase II inhibitor; Monoclonal antibody A7; Vascular permeability

Indexed keywords

ANGIOTENSIN; ENALAPRIL; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANGIOTENSIN II; ANIMAL; ANTIBODIES, MONOCLONAL; BLOOD PRESSURE; CAPILLARY PERMEABILITY; COLONIC NEOPLASMS; ENALAPRIL; FEMALE; HUMAN; MICE; MICE, INBRED BALB C; MICE, NUDE; SUPPORT, NON-U.S. GOV'T;

EID: 0026520905     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1992.tb00093.x     Document Type: Article

References (17)

1. The use of monoclonal antibody conjugates for the diagnosis and treatment of cancer
2. Clinical application of monoclonal antibody drug conjugates for immunotargeting chemotherapy of colorectal carcinoma
3. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors
4. Intratumor factors influencing the access of antibody to tumor cells
5. Involvement of the kinin‐generating cascade in enhanced vascular permeability in tumor tissue
6. Kinin‐generating cascade in advanced cancer patients and in vitro study
7. A monoclonal antibody against human colon cancers
8. Immunochemical characterization of the antigen recognized by the murine monoclonal antibody A7 against colorectal cancer
9. A new approach to cancer chemotherapy. Selective enhancement of tumor blood flow with angiotensin II
10. Increased intratumor concentration of fluorescein‐isothiocyanate‐labeled neocarzinostatin in rats under angiotensin‐induced hypertension
11. Improvement of angiotensin II hypertension cancer chemotherapy
12. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation
13. Enhanced delivery of a monoclonal antibody F(ab′)2 fragment to subcutaneous human glioma xenografts using local hyperthermia
14. 111in‐labeled hapten to bifunctional antibody in human colon tumor xenografts
15. Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug‐monoclonal antibody conjugates
16. Effect of tumor necrosis factor on the antitumor efficacy and toxicity of aminopterin‐monoclonal antibody conjugates: parameters for optimization of therapy
17. Enahnced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate